Biointron Launches RushData, an Integrated Platform for AI-Driven Antibody Discovery with 1-Day CHO Expression
Biointron Biological USA Inc. ("Biointron"), a leading contract research organization for antibody discovery, expression, and optimization, has launched RushData. RushData is an integrated service platform designed to support the growing demands of AI- and machine learning-driven antibody discovery for global pharma and biotech organizations.
